Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 4396 AL 4410

Role of the Personal KinetiGraph in the routine clinical assessment of Parkinson's disease: recommendations from an expert panel

Pahwa R, Isaacson SH, Torres-Russotto D, Nahab FB, Lynch PM, Kotschet KE.

Expert Rev Neurother. 2018 Aug;18(8):669-680. doi: 10.1080/14737175.2018.1503948. Epub 2018 Jul 26.

Lack of central and peripheral nervous system synuclein pathology in R1441G LRRK2-associated Parkinson's disease

Vilas D, Gelpi E, Aldecoa I, Grau O, Rodriguez-Diehl R, Jaumà S, Martí MJ, Tolosa E.

J Neurol Neurosurg Psychiatry. 2019 Jul;90(7):832-833. doi: 10.1136/jnnp-2018-318473. Epub 2018 Jul 27.

The clinical heterogeneity of Parkinson's disease and its therapeutic implications

Greenland JC, Williams-Gray CH, Barker RA.

Eur J Neurosci. 2019 Feb;49(3):328-338. doi: 10.1111/ejn.14094. Epub 2018 Oct 14.

Do Video House Calls With a Specialist Help Get Care to People With Parkinson's Disease?

Dorsey ER, Achey MA, Korn RE, Arky A, Beck CA, Biglan KM, Stevenson EA, Zhu W, Mammen JR, Elson MJ.

Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2018 Aug.

Restless Legs Syndrome and Parkinson Disease: A Causal Relationship Between the Two Disorders?

Ferini-Strambi L, Carli G, Casoni F, Galbiati A.

Front Neurol. 2018 Jul 24;9:551. doi: 10.3389/fneur.2018.00551. eCollection 2018.

Cognitive disorders in normal pressure hydrocephalus with initial parkinsonism in comparison with de novo Parkinson's disease

Picascia M, Pozzi NG, Todisco M, Minafra B, Sinforiani E, Zangaglia R, Ceravolo R, Pacchetti C.

Eur J Neurol. 2019 Jan;26(1):74-79. doi: 10.1111/ene.13766. Epub 2018 Sep 3.

Low-fat versus ketogenic diet in Parkinson's disease: A pilot randomized controlled trial

Phillips MCL, Murtagh DKJ, Gilbertson LJ, Asztely FJS, Lynch CDP.

Mov Disord. 2018 Aug;33(8):1306-1314. doi: 10.1002/mds.27390. Epub 2018 Aug 11.

What influences placebo and nocebo responses in Parkinson's disease?

Witek N, Stebbins GT, Goetz CG.

Mov Disord. 2018 Aug;33(8):1204-1212. doi: 10.1002/mds.27416. Epub 2018 Aug 22.

Motor and Nonmotor Complications of Levodopa: Phenomenology, Risk Factors, and Imaging Features

Ray Chaudhuri K, Poewe W, Brooks D.

Mov Disord. 2018 Jul;33(6):909-919. doi: 10.1002/mds.27386.

Validation of the MDS clinical diagnostic criteria for Parkinson's disease

Postuma RB, Poewe W, Litvan I, Lewis S, Lang AE, Halliday G, Goetz CG, Chan P, Slow E, Seppi K, Schaffer E, Rios-Romenets S, Mi T, Maetzler C, Li Y, Heim B, Bledsoe IO, Berg D.

Mov Disord. 2018 Oct;33(10):1601-1608. doi: 10.1002/mds.27362. Epub 2018 Aug 25.

Harnessing the power of placebos in movement disorders: Insights from Parkinson's disease in clinical research and practice

Mestre TA, Shamy M, Benedetti F, Lang AE.

Mov Disord. 2018 Aug;33(8):1195-1203. doi: 10.1002/mds.27409. Epub 2018 Aug 25.

Parkinson Disease

Homayoun H.

Ann Intern Med. 2018 Sep 4;169(5):ITC33-ITC48. doi: 10.7326/AITC201809040.

Chaperone-mediated autophagy as a therapeutic target for Parkinson disease

Campbell P, Morris H, Schapira A.

Expert Opin Ther Targets. 2018 Oct;22(10):823-832. doi: 10.1080/14728222.2018.1517156. Epub 2018 Sep 10.

Comparison of tractography-assisted to atlas-based targeting for deep brain stimulation in essential tremor

Fenoy AJ, Schiess MC.

Mov Disord. 2018 Dec;33(12):1895-1901. doi: 10.1002/mds.27463. Epub 2018 Sep 5.

Pedunculopontine nucleus: An integrative view with implications on Deep Brain Stimulation

Nowacki A, Galati S, Ai-Schlaeppi J, Bassetti C, Kaelin A, Pollo C.

Neurobiol Dis. 2019 Aug;128:75-85. doi: 10.1016/j.nbd.2018.08.015. Epub 2018 Sep 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias